Surgical Versus Transcatheter Aortic Valve Replacement in Low-Flow, Low-Gradient Aortic Stenosis: Results From 1900 Patients
The Heart Surgery Forum · 23.04.2026 · 29 (4)
DOI: 10.31083/hsf47967 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Heart Surgery Forum, online erschienen am 23.04.2026. Verfasst von Xander Jacquemyn und 9 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Low-flow, low-gradient (LFLG) aortic stenosis (AS) is associated with high-risk physiology and poor outcomes; however, the optimal intervention strategy, surgical aortic valve replacement (SAVR) versus transcatheter aortic valve replacement (TAVR), remains uncertain.
Methods
A systematic review and pooled meta-analysis of studies reporting Kaplan-Meier outcomes after SAVR and TAVR in patients with LFLG AS, published through June 2025, was performed. Individual patient data were reconstructed from published curves. Analyses included Cox frailty models, restricted mean survival time (RMST), and two-stage meta-analyses. Adjusted analyses accounted for baseline differences, including age, comorbidities, and echocardiographic parameters.
Results
Five studies comprising 1940 patients (721 SAVR and 1219 TAVR) were included. Patients undergoing TAVR were older and had higher rates of peripheral arterial disease, while other comorbidities and echocardiographic parameters were similar between groups. In unadjusted analyses, TAVR was associated with higher mortality compared with SAVR (hazard ratio (HR) 1.36, 95% confidence interval (CI) 1.11–1.65; p = 0.003). The estimated 5-year survival was 67% for SAVR versus 49% for TAVR, with an RMST of 0.64 years in favor of SAVR. Despite risk adjustment, TAVR was associated with higher mortality (HR 1.42, 95% CI 1.17–1.73), with a reduction in RMST of 1.06 years. Two-stage meta-analyses yielded consistent findings with low-to-moderate heterogeneity.
Conclusion
SAVR was associated with significantly lower mortality in patients with LFLG AS than TAVR, both before and after risk adjustment. While these findings suggest a potential survival benefit, the data are observational and hypothesis-generating, and residual confounding cannot be excluded.
Zitieren
APA
Jacquemyn, X., Ganduboina, R., Sá, M. P., Hasan, I., Ogami, T., Serna-Gallegos, D., Kliner, D., Toma, C., Makani, A., & Sultan, I. (2026). Surgical Versus Transcatheter Aortic Valve Replacement in Low-Flow, Low-Gradient Aortic Stenosis: Results From 1900 Patients. The Heart Surgery Forum, 29(4). https://doi.org/10.31083/hsf47967
Vancouver
Jacquemyn X, Ganduboina R, Sá MP, Hasan I, Ogami T, Serna-Gallegos D, et al. Surgical Versus Transcatheter Aortic Valve Replacement in Low-Flow, Low-Gradient Aortic Stenosis: Results From 1900 Patients. The Heart Surgery Forum. 2026;29(4). doi:10.31083/hsf47967
BibTeX
@article{Jacquemyn2026,
author = {Jacquemyn, Xander and Ganduboina, Rohit and Sá, Michel Pompeu and Hasan, Irsa and Ogami, Takuya and Serna-Gallegos, Derek and Kliner, Dustin and Toma, Catalin and Makani, Amber and Sultan, Ibrahim},
title = {Surgical Versus Transcatheter Aortic Valve Replacement in Low-Flow, Low-Gradient Aortic Stenosis: Results From 1900 Patients},
journal = {The Heart Surgery Forum},
year = {2026},
volume = {29},
number = {4},
doi = {10.31083/hsf47967}
}
EUVIMED